A recent study by Fonteh et al. and in Alzheimer’s disease patients cerebrospinal fluid has shown that a significant increase in this phospholipase A2 activity accompanies the glycerophospholipid decrease observed in late onset AD patients (Fonteh et al. 2013). The gene discussed is PLB1; the disease is Alzheimer disease.